Deep Machine Learning for Computer-Aided Drug Design
Open Access
- 7 February 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Drug Discovery
- Vol. 2
Abstract
In recent years, deep learning (DL) has led to new scientific developments with immediate implications for computer-aided drug design (CADD). These include advances in both small molecular and macromolecular modeling, as highlighted herein. Going forward, these developments also challenge CADD in different ways and require further progress to fully realize their potential for drug discovery. For CADD, these are exciting times and at the very least, the dynamics of the discipline will further increase.Keywords
This publication has 40 references indexed in Scilit:
- Free Energy Methods in Drug Design: Prospects of “Alchemical Perturbation” in Medicinal ChemistryJournal of Medicinal Chemistry, 2017
- Can we open the black box of AI?Nature, 2016
- A renaissance of neural networks in drug discoveryExpert Opinion on Drug Discovery, 2016
- Computer-aided drug discoveryF1000Research, 2015
- Deep learningNature, 2015
- Accurate and Reliable Prediction of Relative Ligand Binding Potency in Prospective Drug Discovery by Way of a Modern Free-Energy Calculation Protocol and Force FieldJournal of the American Chemical Society, 2015
- Molecular Similarity in Medicinal ChemistryJournal of Medicinal Chemistry, 2013
- Protein 3D Structure Computed from Evolutionary Sequence VariationPLOS ONE, 2011
- Similarity methods in chemoinformaticsAnnual Review of Information Science and Technology, 2009
- The Many Roles of Computation in Drug DiscoveryScience, 2004